Torrent Pharma, CG Consumer & KPIT Tech In Focus! | Stock Market

Torrent Pharma management believes its generics have bottomed out and are expected to recover in the coming quarters. The balance sheet is expected to be net cash positive in H2 FY26. They continue to look for inorganic opportunities. CG Consumer says they can double their business in 5 years and see margin expansion driven by operating leverage. They undertook a general price increase of 4-5%; Expect more price hikes in Q1FY25. KPIT Tech says they see stable growth visibility for the next 4-year period. Deals won, customer activity, conversions and success rates remain stable. Listen to know more!#banknifty #nifty #niftybank #sensex #niftystrategies #nifty50 #stockmarket #stockmarketanalysis #stocknews

Leave a Comment


No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *